Metabolic Effect of Spexin on Obesity and Diabetes: A Mini Review
Iraqi Journal of Medical Sciences · 26.06.2026 · 24 (1) · 129-136
DOI: 10.22578/z0qtq635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iraqi Journal of Medical Sciences, online erschienen am 26.06.2026. Verfasst von Sura A. Abdulsattar und 2 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Spexin is an adipokine and neuropeptide that is extensively expressed in a number of tissues and organs, like the pancreas, fat, small intestine, liver, stomach, and other endocrine tissues to perform a variety of functions such as glucose and lipid metabolism. Spexin might be a biomarker for insulin resistance, diabetes, and obesity, where it is a potent adipose cell metabolism regulator that improves insulin sensitivity in diabetes and obesity by inhibiting adipogenesis, promoting adipose tissue browning and lipolysis, increasing body thermogenesis and energy expenditure. An updated explanation of spexin and mechanism action of this peptide as an efficient treatment to prevent obesity and diabetes were the aims of this review. Keywords Insulin, lipid, metabolic effect, obesity, Spexin, resistance, T2DM
Zitieren
APA
Abdulsattar, S. A., Al-Ani, R. H., & Naji, T. S. (2026). Metabolic Effect of Spexin on Obesity and Diabetes: A Mini Review. Iraqi Journal of Medical Sciences, 24(1), 129-136. https://doi.org/10.22578/z0qtq635
Vancouver
Abdulsattar SA, Al-Ani RH, Naji TS. Metabolic Effect of Spexin on Obesity and Diabetes: A Mini Review. Iraqi Journal of Medical Sciences. 2026;24(1):129-136. doi:10.22578/z0qtq635
BibTeX
@article{Abdulsattar2026,
author = {Abdulsattar, Sura A. and Al-Ani, Raghad H. and Naji, Tamara S.},
title = {Metabolic Effect of Spexin on Obesity and Diabetes: A Mini Review},
journal = {Iraqi Journal of Medical Sciences},
year = {2026},
volume = {24},
number = {1},
pages = {129--136},
doi = {10.22578/z0qtq635}
}
EUVIMED